Glow Medical Spa
What your business looks like from the outside, and where the gaps are.
‘Full-service med spa’ is the most crowded positioning in Denver, and Glow is sitting on a gap
Service stack: injectables, laser, body contouring, GLP-1, IV therapy, hormone replacement. Homepage currently leads with a promotion.
Glow offers hormone replacement alongside aesthetics. In Denver's 35-55F demographic, this is a genuine differentiator. No Cherry Creek competitor is leading with this combination explicitly. A patient with hormone and aesthetic goals who lands on the homepage sees a discount offer, not the clinical depth that would make them choose Glow over a discount competitor.
No Cherry Creek competitor is leading with this. In the 35-55F demographic, this combination commands a premium and reduces price sensitivity.
The right patient lands on the homepage and sees a discount. That framing attracts the wrong buyer and undersells clinical depth.
Rewrite the homepage hero. Build a dedicated HRT page targeting 'hormone therapy Denver med spa.' Low competition, high buyer intent.
Weight loss is Glow's fastest-growing revenue line, and its most exposed
Semaglutide, tirzepatide, B12/lipotropic · $350/month · monthly check-ins, lab review · CareCredit accepted · no bundled aesthetics pathway at intake
$350/month is competitive in Denver. CareCredit removes the affordability objection for the first 90 days. The program is converting at the top of funnel. The exposure: FDA enforcement on compounded semaglutide tightened through 2024-25. And the downstream opportunity, GLP-1 patients who lose 15-30 lbs are highly motivated aesthetic buyers within 6-9 months, is currently unaddressed. No intake pathway connects weight loss to body contouring or skin tightening consultation.
$350/month is competitive. CareCredit removes the first-90-day affordability objection. Top-of-funnel is converting.
If the program relies on compounded product, the revenue line has regulatory exposure. Branded supply is more stable but at higher cost. Margin compression is the risk.
GLP-1 patients become motivated aesthetic buyers in 6-9 months. Glow has the stack. There is no documented pathway connecting them. Build it now while patients are still in program.
The membership structure that wins in Cherry Creek has changed. Glow hasn't caught up
This section covers published pricing as a competitive advantage, tier structure gaps against two leading competitors, and a specific Monday-morning move to capture the high-LTV client segment.
Cherry Creek is the highest-density med spa corridor in Denver. Glow is mid-pack
| Competitor | Reviews | Rating | Local Pack | Membership | Signal |
|---|---|---|---|---|---|
Full competitive breakdown with review velocity, positioning hooks, and local pack positions.
The moves that matter this year
3 prioritized actions with direct revenue impact. Specific to this business, this market, this year.